← Leaderboards
Alan D Friedman
Johns Hopkins University
$19,368,190
Attributed
$19,388,690
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,388,690 · 8
By mechanism
U01$8,393,647 · 1
R01$7,825,820 · 5
T32$3,128,223 · 1
R03$41,000 · 1
Top collaborators
- Elias T Zambidis1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Carl A Latkin$38,006,118
- Lawrence John Appel$45,566,796
- Nicholas S Ialongo$26,586,427
- Susan L Furth$36,670,372
- Vivian F. Go$15,157,279
Others in their field
Top investigators on “Marrow”
- Mary M Horowitz · Medical College Of Wisconsin$225,743,807
- Charles A Coltman · Southwest Oncology Group$141,983,231
- David Heimbrook · Leidos Biomedical Research, Inc.$56,049,457
- Richard L Schilsky · University Of Chicago$50,043,295
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$48,148,202
- David T Scadden · Massachusetts General Hospital$34,229,668
Research focus
MarrowPathway InteractionsGenerationsProgenitorHematopoiesisCellsGenetic TranscriptionMediatingSignal TransductionGeneticBaseComplexEpigenetic ProcessMonocyteTranscription FactorGenesProteinsMyelogenousMutationPreventLaboratory MouseLeadIn VivoHematopoietic
Grant awards (35)
Lab Research Training in Pediatric Oncology-Hematology$666,679
T32 · FY2025 · CA · contact PI
Lab Research Training in Pediatric Oncology-Hematology$665,090
T32 · FY2024 · CA · contact PI
Lab Research Training in Pediatric Oncology-Hematology$585,732
T32 · FY2023 · CA · contact PI
Lab Research Training in Pediatric Oncology-Hematology$637,153
T32 · FY2022 · CA · contact PI
Lab Research Training in Pediatric Oncology-Hematology$573,569
T32 · FY2021 · CA · contact PI
The Cebpa Enhancer in Normal Hematopoiesis and Progression to AML$405,000
R01 · FY2019 · HL · contact PI
The Cebpa Enhancer in Normal Hematopoiesis and Progression to AML$405,000
R01 · FY2018 · HL · contact PI
The Cebpa Enhancer in Normal Hematopoiesis and Progression to AML$405,000
R01 · FY2017 · HL · contact PI
The Cebpa Enhancer in Normal Hematopoiesis and Progression to AML$405,000
R01 · FY2016 · HL · contact PI
Basic and Translational Research of iPSC-Based hematologic and Vascular Therapies$1,184,806
U01 · FY2015 · HL · contact PI
Basic and Translational Research of iPSC-Based hematologic and Vascular Therapies$1,178,791
U01 · FY2014 · HL · contact PI
Basic and Translational Research of iPSC-Based hematologic and Vascular Therapies$1,159,250
U01 · FY2013 · HL · contact PI
Regulation of Monocyte and Granulocyte Lineage Specification$386,417
R01 · FY2013 · HL · contact PI
Basic and Translational Research of iPSC-Based hematologic and Vascular Therapies$1,217,700
U01 · FY2012 · HL · contact PI
Regulation of Monocyte and Granulocyte Lineage Specification$405,900
R01 · FY2012 · HL · contact PI
Basic and Translational Research of iPSC-Based hematologic and Vascular Therapies$1,217,700
U01 · FY2011 · HL · contact PI
Regulation of Monocyte and Granulocyte Lineage Specification$410,000
R01 · FY2011 · HL · contact PI
Basic and Translational Research of iPSC-Based hematologic and Vascular Therapies$1,205,400
U01 · FY2010 · HL · contact PI
Regulation of Monocyte and Granulocyte Lineage Specification$410,000
R01 · FY2010 · HL · contact PI
Basic and Translational Research of iPSC-Based hematologic and Vascular Therapies$1,230,000
U01 · FY2009 · HL · contact PI
Regulation of Monocyte and Granulocyte Lineage Specification$410,000
R01 · FY2009 · HL · contact PI
Transcriptional and Epigenetic Regulation of HSC Generated from iPS and ESC$41,000
R03 · FY2009 · HL · contact PI
Role of C/EBPalpha in MDS and MDS Progression$349,879
R01 · FY2008 · HL · contact PI
Role of C/EBPalpha in MDS and MDS Progression$349,879
R01 · FY2007 · HL · contact PI
Cell Cycle Regulation and Leukemogenesis by CBFb-SMMHC$310,442
R01 · FY2007 · CA · contact PI
Role of C/EBPalpha in MDS and MDS Progression$359,414
R01 · FY2006 · HL · contact PI
Cell Cycle Regulation and Leukemogenesis by CBFb-SMMHC$319,714
R01 · FY2006 · CA · contact PI
Role of C/EBPalpha in MDS and MDS Progression$366,938
R01 · FY2005 · HL
Cell Cycle Regulation and Leukemogenesis by CBFb-SMMHC$327,409
R01 · FY2005 · CA
Cell Cycle Regulation and Leukemogenesis by CBFb-SMMHC$327,409
R01 · FY2004 · CA
A TRANSCRIPTIONAL PROGRAM REGULATING MYELOPOIESIS$286,125
R01 · FY2004 · HL
Cell Cycle Regulation and Leukemogenesis by CBFb-SMMHC$327,409
R01 · FY2003 · CA
A TRANSCRIPTIONAL PROGRAM REGULATING MYELOPOIESIS$286,125
R01 · FY2003 · HL
A TRANSCRIPTIONAL PROGRAM REGULATING MYELOPOIESIS$286,125
R01 · FY2002 · HL
A TRANSCRIPTIONAL PROGRAM REGULATING MYELOPOIESIS$286,635
R01 · FY2001 · HL